Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Canada's Cineplex adopts poison pill

Published 06/19/2020, 05:54 PM
Updated 06/19/2020, 05:55 PM
© Reuters. A Cineplex movie theatre sign looms over Yonge street in Toronto

© Reuters. A Cineplex movie theatre sign looms over Yonge street in Toronto

(Reuters) - Cineplex Inc (TO:CGX) said on Friday it adopted a shareholder rights plan, popularly known as a "poison pill", nearly a week after Britain's Cineworld Group Plc (L:CINE) abandoned its $1.65 billion deal to buy the Canadian theater chain.

The implementation of the rights plan will prevent investors from acquiring 20% or more of the company's outstanding common shares without complying with certain provisions of the plan, Cineplex said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=

Cineworld scrapped the deal last week citing what it termed Cineplex's breaches in the merger agreement between the cinema operators.

The rights plan has not been adopted in response to any specific takeover bid or other proposal to acquire control of Cineplex, it added.

© Reuters. A Cineplex movie theatre sign looms over Yonge street in Toronto

Cineplex said the rights plan is subject to ratification by the company's shareholders and will have an initial term of three years.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.